Cargando…

Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings

PURPOSE: To explore the effects of Icaritin on chronic myeloid leukemia (CML) cells and underlying mechanisms. METHOD: CML cells were incubated with various concentration of Icaritin for 48 hours, the cell proliferation was analyzed by MTT and the apoptosis was assessed with Annexin V and Hoechst 33...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jian feng, Li, Zi jian, Zhang, Guang sen, Meng, Kun, Kuang, Wen yong, Li, Jin, Zhou, Xin fu, Li, Rui juan, Peng, Hong ling, Dai, Chong wen, Shen, Jian Kai, Gong, Fan jie, Xu, Yun xiao, Liu, Su fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161749/ https://www.ncbi.nlm.nih.gov/pubmed/21887305 http://dx.doi.org/10.1371/journal.pone.0023720

Ejemplares similares

Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
por: Li, Shasha, et al.
Publicado: (2013)

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
por: Zhu, Shicong, et al.
Publicado: (2015)

JAK-STAT in Early Hematopoiesis and Leukemia
por: Fasouli, Eirini Sofia, et al.
Publicado: (2021)

Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells
por: Zhao, Qiaoli, et al.
Publicado: (2015)

Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy
por: Yang, Xiao-Jing, et al.
Publicado: (2019)

Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway
por: Tan, Jinshui, et al.
Publicado: (2023)

Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells
por: Ma, Lingdi, et al.
Publicado: (2017)

The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia
por: Li, Zi-ye, et al.
Publicado: (2018)

Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling
por: Yang, Jian-Guang, et al.
Publicado: (2017)

Cytotoxic Effect of Icaritin and Its Mechanisms in Inducing Apoptosis in Human Burkitt Lymphoma Cell Line
por: Li, Zi-Jian, et al.
Publicado: (2014)

Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK Pathways
por: Yang, Chu-Wen, et al.
Publicado: (2012)

Ciliary Neurotrophic Factor Derived From Astrocytes Protects Retinal Ganglion Cells Through PI3K/AKT, JAK/STAT, and MAPK/ERK Pathways
por: Lee, Kwanghyun, et al.
Publicado: (2022)

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
por: Zhao, Hong, et al.
Publicado: (2015)

A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
por: Li, Haowen, et al.
Publicado: (2020)

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma
por: Ramis-Zaldivar, Joan Enric, et al.
Publicado: (2021)

In vitro and in vivo modelling of mutant JAK3/STAT5 signaling in leukemia
por: Omari, Sofia A., et al.
Publicado: (2023)

MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia
por: Lei, Bo, et al.
Publicado: (2020)

Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma
por: Zheng, Xia, et al.
Publicado: (2021)

Rapamycin-Induced Apoptosis in HGF-Stimulated Lens Epithelial Cells by AKT/mTOR, ERK and JAK2/STAT3 Pathways
por: Tian, Fang, et al.
Publicado: (2014)

Corrigendum to “the long noncoding RNA MEG3 and its target miR-147 regulate JAK/STAT pathway in advanced chronic myeloid leukemia” [EBioMedicine 35 (2018) 61–75]
por: Li, Zi-ye, et al.
Publicado: (2018)

Sodium Ferulate Protects against Angiotensin II-Induced Cardiac Hypertrophy in Mice by Regulating the MAPK/ERK and JNK Pathways
por: Hu, Bo, et al.
Publicado: (2017)

Magnoliae flos Downregulated Lipopolysaccharide-Induced Inflammatory Responses via NF-κB/ERK-JNK MAPK/STAT3 Pathways
por: Gil, Tae-Young, et al.
Publicado: (2022)

CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of ERK/JNK/p38-MAPK signaling pathways
por: Xin, Wenhu, et al.
Publicado: (2022)

Highly efficient bioconversion of icariin to icaritin by whole-cell catalysis
por: Lin, Yu, et al.
Publicado: (2023)

The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus
por: Teng, Jia-An, et al.
Publicado: (2016)

Role of GADD45A in myocardial ischemia/reperfusion through mediation of the JNK/p38 MAPK and STAT3/VEGF pathways
por: Wang, Yang, et al.
Publicado: (2022)

Targeting the MAPK/ERK and PI3K/AKT Signaling Pathways Affects NRF2, Trx and GSH Antioxidant Systems in Leukemia Cells
por: Jasek-Gajda, Ewa, et al.
Publicado: (2020)

Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005)

Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity
por: Mhone, Thomas Gabriel, et al.
Publicado: (2022)

Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions
por: Shen, Chang-peng, et al.
Publicado: (2004)

Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways
por: Nakamura, Koichi, et al.
Publicado: (2023)

Chronic activation of JNK JAK/STAT and oxidative stress signalling causes the loser cell status
por: Kucinski, Iwo, et al.
Publicado: (2017)

Leptin Promotes the Proliferation and Neuronal Differentiation of Neural Stem Cells through the Cooperative Action of MAPK/ERK1/2, JAK2/STAT3 and PI3K/AKT Signaling Pathways
por: Tan, Ruolan, et al.
Publicado: (2023)

Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series
por: Hu, Mengze, et al.
Publicado: (2023)

A Novel Antithrombocytopenia Agent, Rhizoma cibotii, Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways
por: Chen, Wang, et al.
Publicado: (2022)

The T-cell leukemia associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
por: Girardi, Tiziana, et al.
Publicado: (2017)

Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia
por: Sharma, Nitesh D., et al.
Publicado: (2019)

Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells
por: Al-Rawashde, Futoon Abedrabbu, et al.
Publicado: (2021)

Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
por: Tong, Jing-Shan, et al.
Publicado: (2011)

Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
por: Fang, Zhiqing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sdbmg9ltbcjqs0541v1lrtb47e